Detailed information of NR3C1

  1. Home
  2. TF > NR3C1

Dataset summary

TF Name: NR3C1 Species: Homo sapiens
Cell-type/Tissue: THP-1 (acute monocytic leukemia) Condition/Source: Treatment: untreated Tissue: peripheral blood-derived Sex: male
JASPAR ID: MA0113.3 Collections: Permissive
References: GEO GSE99887 GSM2661790 GSM2661792 GTRD EXP049917 PUBMED 29170386

External links

Models for profile: MA0113.3

Download TFBSs (hg38)

Download TFBSs in BED and FASTA format

Download trained model

Download trained prediction models

Visualize TFBSs in UCSC

Send TFBSs BED file to UCSC genome browser

Summary plots

Statistical details

Model Peak caller Model ID Enrichment Zone TFBSs Score threshold Centrality p-value (log10)
DAMO MACS MA0113.3 13 363 83.8 0.0

225 datasets found for the same TF (NR3C1) in other cell-types/tissues

TF Name Cell-line Condition/Source Collections Species Identifiers JASPAR ID
NR3C1 A549 (lung carcinoma) 1 h with 500 pM Dexamethasone (Myers) Permissive Homo sapiens ENCSR000BHE MA0113.3
NR3C1 A549 (lung carcinoma) 1 h with 50 nM Dexamethasone (Myers) Permissive Robust Homo sapiens ENCSR000BHF MA0113.3
NR3C1 A549 (lung carcinoma) 1 h with 5 nM Dexamethasone (Myers) Permissive Robust Homo sapiens ENCSR000BHG MA0113.3
NR3C1 A549 (lung carcinoma) 1 h with 0.02% Ethanol (Myers) Permissive Homo sapiens ENCSR000BIO MA0113.3
NR3C1 Ishikawa (endometrial adenocarcinoma) 1 h with 100 nM Dexamethasone (Myers) Permissive Homo sapiens ENCSR000BJC MA0113.3
NR3C1 A549 (lung carcinoma) 1 h with 100 nM Dexamethasone (Myers) Permissive Robust Homo sapiens ENCSR000BJR MA0113.3
NR3C1 A549 (lung carcinoma) 1 h with 0.02% Ethanol (Myers) Permissive Homo sapiens ENCSR000BJT MA0113.3
NR3C1 Ishikawa (endometrial adenocarcinoma) 1 h with 0.02% Ethanol (Myers) Permissive Homo sapiens ENCSR000BLB MA0113.3
NR3C1 HepG2 (hepatoblastoma) low-glucose DMEM with 0.5% BSA supplemented with 1uM forskolin and 1mM pyruvate for 6h. (Snyder) Permissive Robust Homo sapiens ENCSR000EEV MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 20 minute Permissive Robust Homo sapiens ENCSR458VTP MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 10 minute Permissive Robust Homo sapiens ENCSR471EKW MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 25 minute Permissive Robust Homo sapiens ENCSR070VXO MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 15 minute Permissive Robust Homo sapiens ENCSR908AOO MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 5 minute Permissive Robust Homo sapiens ENCSR857QEA MA0113.3
NR3C1 3T3-L1-derived preadipocytes 4 hours of differentiation Permissive Robust Mus musculus GSE27826 ... MA0113.3
NR3C1 BMDM (bone marrow-derived macrophages) Dexamethasone treated, unstimulated Permissive Robust Mus musculus GSE31796 ... MA0113.3
NR3C1 BMDM (bone marrow-derived macrophages) Dexamethasone treated, LPS-stimulated Permissive Robust Mus musculus GSE31796 ... MA0113.3
NR3C1 BMDM (bone marrow-derived macrophages) LPS-stimulated macrophages Permissive Mus musculus GSE31796 ... MA0113.3
NR3C1 BMDM (bone marrow-derived macrophages) Dexamethasone treated, LPS-stimulated macrophages Permissive Mus musculus GSE31796 ... MA0113.3
NR3C1 LNCaP (prostate carcinoma) 100 nM DEX Permissive Robust Homo sapiens GSE39879 ... MA0113.3
NR3C1 VCaP (prostate carcinoma) 100 nM DEX Permissive Homo sapiens GSE39879 ... MA0113.3
NR3C1 LNCaP (prostate carcinoma) 100 nM Dex Permissive Robust Homo sapiens GSE39879 ... MA0113.3
NR3C1 LNCaP (prostate carcinoma) 100 nM DHT+Dex Permissive Robust Homo sapiens GSE39879 ... MA0113.3
NR3C1 AtT-20 (pituitary tumor) Dex+LIF Permissive Robust Mus musculus GSE37235 ... MA0113.3
NR3C1 AtT-20 (pituitary tumor) Dex Permissive Robust Mus musculus GSE37235 ... MA0113.3
NR3C1 liver Ad-lib fed Permissive Robust Mus musculus GSE45674 ... MA0113.3
NR3C1 liver veh Permissive Mus musculus GSE46047 ... MA0113.3
NR3C1 liver dex Permissive Robust Mus musculus GSE46047 ... MA0113.3
NR3C1 liver dex adGFP Permissive Robust Mus musculus GSE46047 ... MA0113.3
NR3C1 liver dex adDN-C/EBP Permissive Robust Mus musculus GSE46047 ... MA0113.3
NR3C1 mammary cells untreated Permissive Mus musculus GSE46123 ... MA0113.3
NR3C1 mammary cells Dexamethasone for 30 minutes Permissive Robust Mus musculus GSE46123 ... MA0113.3
NR3C1 mammary cells Estradiol for 30 minutes Permissive Mus musculus GSE46123 ... MA0113.3
NR3C1 mammary cells Dexamethasone + Estradiol for 30 minutes Permissive Robust Mus musculus GSE46123 ... MA0113.3
NR3C1 7438 (mammary carcinoma) untreated Permissive Mus musculus GSE46123 ... MA0113.3
NR3C1 7438 (mammary carcinoma) Dexamethasone for 30 minutes Permissive Robust Mus musculus GSE46123 ... MA0113.3
NR3C1 7438 (mammary carcinoma) Estradiol for 30 minutes Permissive Robust Mus musculus GSE46123 ... MA0113.3
NR3C1 7438 (mammary carcinoma) Dexamethasone + Estradiol for 30 minutes Permissive Robust Mus musculus GSE46123 ... MA0113.3
NR3C1 embryonic kidney dexamethasone Permissive Robust Homo sapiens GSE48374 ... MA0113.3
NR3C1 embryonic kidney dexamethasone, stably expressing wt GR Permissive Robust Homo sapiens GSE48374 ... MA0113.3
NR3C1 embryonic kidney dexamethasone, stably expressing SUMOylation-defective GR Permissive Robust Homo sapiens GSE48374 ... MA0113.3
NR3C1 MDA-MB-231 (breast adenocarcinoma) dexametasone Permissive Robust Homo sapiens GSE56022 ... MA0113.3
NR3C1 MDA-MB-231 (breast adenocarcinoma) compaund A Permissive Homo sapiens GSE56022 ... MA0113.3
NR3C1 acute myeloblastic leukemia dexametasone Permissive Robust Homo sapiens GSE58266 ... MA0113.3
NR3C1 liver none Permissive Mus musculus GSE59752 ... MA0113.3
NR3C1 liver none Permissive Mus musculus GSE59752 ... MA0113.3
NR3C1 liver prednisolone Permissive Mus musculus GSE59752 ... MA0113.3
NR3C1 liver none Permissive Robust Mus musculus GSE59752 ... MA0113.3
NR3C1 liver none Permissive Robust Mus musculus GSE59752 ... MA0113.3
NR3C1 liver prednisolone Permissive Robust Mus musculus GSE59752 ... MA0113.3
NR3C1 BMDM (bone marrow-derived macrophages) dexamethasone and (or) lipopolysaccharide Permissive Robust Mus musculus GSE59764 ... MA0113.3
NR3C1 BMDM (bone marrow-derived macrophages) dexamethasone and (or) lipopolysaccharide Permissive Mus musculus GSE59764 ... MA0113.3
NR3C1 3134 (mammary adenocarcinoma) cort for 20min Permissive Robust Mus musculus GSE61234 ... MA0113.3
NR3C1 3134 (mammary adenocarcinoma) cort pulsed 60min Permissive Robust Mus musculus GSE61234 ... MA0113.3
NR3C1 3134 (mammary adenocarcinoma) cort constant 60min Permissive Robust Mus musculus GSE61234 ... MA0113.3
NR3C1 retina dex Permissive Robust Mus musculus GSE61877 ... MA0113.3
NR3C1 burst-forming unit erythroid Dexamethasone 4 hrs Permissive Mus musculus GSE62788 ... MA0113.3
NR3C1 burst-forming unit erythroid Dexamethasone and GW7647 4 hrs Permissive Mus musculus GSE62788 ... MA0113.3
NR3C1 HEK293T (embryonic kidney) Dexamethasone (24h) Permissive Homo sapiens GSE64171 ... MA0113.3
NR3C1 white adipose tissue standard rodent chow diet Permissive Robust Mus musculus GSE64458 ... MA0113.3
NR3C1 inguinal white adipose tissue standard rodent chow diet Permissive Robust Mus musculus GSE64458 ... MA0113.3
NR3C1 embryonic fibroblasts dexametasone Permissive Robust Mus musculus GSE69947 ... MA0113.3
NR3C1 embryonic fibroblasts Klf15 -/- Permissive Mus musculus GSE69947 ... MA0113.3
NR3C1 embryonic fibroblasts dexametasone, Klf15 -/- Permissive Mus musculus GSE69947 ... MA0113.3
NR3C1 mammary gland lactation day 1, Wap-delE1a Permissive Robust Mus musculus GSE74826 ... MA0113.3
NR3C1 mammary gland lactation day 1, Wap-delE1b Permissive Mus musculus GSE74826 ... MA0113.3
NR3C1 mammary gland lactation day 1, Wap-delE1c Permissive Robust Mus musculus GSE74826 ... MA0113.3
NR3C1 mammary gland lactation day 1, Wap-delE2 Permissive Robust Mus musculus GSE74826 ... MA0113.3
NR3C1 mammary gland lactation day 1, Wap-delE3 Permissive Robust Mus musculus GSE74826 ... MA0113.3
NR3C1 mammary gland lactation day 1 Permissive Robust Mus musculus GSE74826 ... MA0113.3
NR3C1 mammary gland pregnancy day 13 Permissive Mus musculus GSE74826 ... MA0113.3
NR3C1 A549 (lung carcinoma) dex Permissive Homo sapiens GSE79431 ... MA0113.3
NR3C1 A549 (lung carcinoma) etoh Permissive Robust Homo sapiens GSE79431 ... MA0113.3
NR3C1 BEAS-2B (bronchial epithelium) dexamethasone Permissive Robust Homo sapiens GSE79803 ... MA0113.3
NR3C1 BEAS-2B (bronchial epithelium) dexamethasone + TNF Permissive Robust Homo sapiens GSE79803 ... MA0113.3
NR3C1 BEAS-2B (bronchial epithelium) vehicle Permissive Homo sapiens GSE79803 ... MA0113.3
NR3C1 mammary gland lactation day one Permissive Robust Mus musculus GSE84115 ... MA0113.3
NR3C1 mammary gland involution 12 hours Permissive Mus musculus GSE84115 ... MA0113.3
NR3C1 mammary gland involution 24 hours Permissive Mus musculus GSE84115 ... MA0113.3
NR3C1 hepatocytes fed 10 h Permissive Robust Mus musculus GSE72084 ... MA0113.3
NR3C1 hepatocytes fasted 24 h Permissive Robust Mus musculus GSE72084 ... MA0113.3
NR3C1 hepatocytes glucagon (10nM) + corticosterone (1.7uM) for 1hr Permissive Robust Mus musculus GSE72084 ... MA0113.3
NR3C1 brown preadipocytes GR KO Permissive Mus musculus GSE76619 ... MA0113.3
NR3C1 MCF7 (Invasive ductal breast carcinoma) ICI Permissive Homo sapiens GSE81510 ... MA0113.3
NR3C1 MCF7 (Invasive ductal breast carcinoma) ICI, DEX Permissive Robust Homo sapiens GSE81510 ... MA0113.3
NR3C1 MCF7 (Invasive ductal breast carcinoma) E2 Permissive Homo sapiens GSE81510 ... MA0113.3
NR3C1 MCF7 (Invasive ductal breast carcinoma) E2, DEX Permissive Robust Homo sapiens GSE81510 ... MA0113.3
NR3C1 MCF7 (Invasive ductal breast carcinoma) ICI, pBox mutant Permissive Homo sapiens GSE81510 ... MA0113.3
NR3C1 MCF7 (Invasive ductal breast carcinoma) ICI, DEX, pBox mutant Permissive Robust Homo sapiens GSE81510 ... MA0113.3
NR3C1 MCF7 (Invasive ductal breast carcinoma) E2, pBox mutant Permissive Homo sapiens GSE81510 ... MA0113.3
NR3C1 MCF7 (Invasive ductal breast carcinoma) E2, DEX, pBox mutant Permissive Homo sapiens GSE81510 ... MA0113.3
NR3C1 mammary gland Socs2 mut, pregnancy day13 Permissive Robust Mus musculus GSE82275 ... MA0113.3
NR3C1 mammary gland delA mutant Permissive Robust Mus musculus GSE92591 ... MA0113.3
NR3C1 mammary gland delC mutant Permissive Robust Mus musculus GSE92591 ... MA0113.3
NR3C1 bone marrow-derived macrophages Dex/DSG+FA Permissive Robust Mus musculus GSE93736 ... MA0113.3
NR3C1 bone marrow-derived macrophages LPS+Dex/DSG+FA Permissive Robust Mus musculus GSE93736 ... MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 7 hour Permissive Robust Homo sapiens ENCSR952GOL MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 12 hour Permissive Robust Homo sapiens ENCSR287FWE MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 3 hour Permissive Robust Homo sapiens ENCSR385RUW MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 6 hour Permissive Robust Homo sapiens ENCSR424JOE MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 4 hour Permissive Robust Homo sapiens ENCSR660RYY MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 5 hour Permissive Robust Homo sapiens ENCSR686PFM MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 30 minute Permissive Robust Homo sapiens ENCSR773NQB MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 10 hour Permissive Robust Homo sapiens ENCSR255CTA MA0113.3
NR3C1 A549 (lung carcinoma) 100nM dexamethasone (CHEBI:41879) for 8 hour Permissive Robust Homo sapiens ENCSR691GRA MA0113.3
NR3C1 MCF-7 C4-12 (invasive breast ductal carcinoma) Female Permissive Robust Homo sapiens GSE104399 ... MA0113.3
NR3C1 breast tumor Male Permissive Robust Homo sapiens GSE104399 ... MA0113.3
NR3C1 MCF10A (breast epithelial cells) Treatment: untreated; Permissive Robust Homo sapiens GSE102355 ... MA0113.3
NR3C1 MCF10A (breast epithelial cells) Treatment: untreated; Permissive Robust Homo sapiens GSE102355 ... MA0113.3
NR3C1 MCF10A (breast epithelial cells) Treatment: dexamethasone (DEX) 20 min; Permissive Robust Homo sapiens GSE102355 ... MA0113.3
NR3C1 MCF10A (breast epithelial cells) Treatment: dexamethasone (DEX) 20 min; Permissive Robust Homo sapiens GSE102355 ... MA0113.3
NR3C1 MCF10A (breast epithelial cells) Treatment: dexamethasone (DEX) 60 min; Permissive Robust Homo sapiens GSE102355 ... MA0113.3
NR3C1 MCF10A (breast epithelial cells) Treatment: dexamethasone (DEX) 60 min; Permissive Robust Homo sapiens GSE102355 ... MA0113.3
NR3C1 MCF10A (breast epithelial cells) Treatment: EGF + DEX 20 min; Permissive Robust Homo sapiens GSE102355 ... MA0113.3
NR3C1 MCF10A (breast epithelial cells) Treatment: EGF + DEX 20 min; Permissive Robust Homo sapiens GSE102355 ... MA0113.3
NR3C1 MCF10A (breast epithelial cells) Treatment: EGF + DEX 60 min; Permissive Robust Homo sapiens GSE102355 ... MA0113.3
NR3C1 MCF10A (breast epithelial cells) Treatment: EGF + DEX 60 min; Permissive Robust Homo sapiens GSE102355 ... MA0113.3
NR3C1 Ishikawa (endometrial adenocarcinoma) Treatment: 100 nM Dexamethasone and 10 nM Estradiol for 1 hour Permissive Robust Homo sapiens GSE109891 ... MA0113.3
NR3C1 Ishikawa (endometrial adenocarcinoma) Treatment: 100 nM Dexamethasone for 1 hour Permissive Robust Homo sapiens GSE109891 ... MA0113.3
NR3C1 Ishikawa (endometrial adenocarcinoma) Treatment: DMSO (vehicle) for 1 hour Permissive Homo sapiens GSE109891 ... MA0113.3
NR3C1 A1-2 (breast cancer cells) Treatment: 1hr EtOH Permissive Homo sapiens GSE112491 ... MA0113.3
NR3C1 A1-2 (breast cancer cells) Treatment: 1hr Dex Permissive Robust Homo sapiens GSE112491 ... MA0113.3
NR3C1 HASM2 (Human airway smooth muscle 2) Treatment: EtOH for 4 hr Permissive Homo sapiens GSE95632 ... MA0113.3
NR3C1 HASM2 (Human airway smooth muscle 2) Treatment: EtOH for 4 hr Permissive Homo sapiens GSE95632 ... MA0113.3
NR3C1 HASM2 (Human airway smooth muscle 2) Treatment: dexamethasone for 4 hr Permissive Robust Homo sapiens GSE95632 ... MA0113.3
NR3C1 HASM2 (Human airway smooth muscle 2) Treatment: dexamethasone for 4 hr Permissive Robust Homo sapiens GSE95632 ... MA0113.3
NR3C1 HASM2 (Human airway smooth muscle 2) Treatment: dexamethasone for 4 hr Genotype: Ad-GFP transduction Permissive Robust Homo sapiens GSE95632 ... MA0113.3
NR3C1 HASM2 (Human airway smooth muscle 2) Treatment: dexamethasone for 4 hr Genotype: Ad-GFP transduction Permissive Robust Homo sapiens GSE95632 ... MA0113.3
NR3C1 HASM2 (Human airway smooth muscle 2) Treatment: dexamethasone for 4 hr Genotype: Ad-KLF15 transduction Permissive Robust Homo sapiens GSE95632 ... MA0113.3
NR3C1 HASM2 (Human airway smooth muscle 2) Treatment: dexamethasone for 4 hr Genotype: Ad-KLF15 transduction Permissive Robust Homo sapiens GSE95632 ... MA0113.3
NR3C1 granulocyte macrophage progenitors Treatment: untreated Tissue: bone marrow -derived Age: 8-10 weeks Sex: male Strain: C57BL/6 Permissive Mus musculus GSE99887 ... MA0113.3
NR3C1 granulocyte macrophage progenitors Treatment: Dex, 100nm, 45 min Tissue: bone marrow -derived Age: 8-10 weeks Sex: male Strain: C57BL/6 Permissive Robust Mus musculus GSE99887 ... MA0113.3
NR3C1 THP-1 (acute monocytic leukemia) Treatment: Dex, 100 nM, 1hour Tissue: peripheral blood-derived Sex: male Permissive Robust Homo sapiens GSE99887 ... MA0113.3
NR3C1 BMDM (bone marrow-derived macrophages) Treatment: 100 nM Dex for 45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6 Permissive Robust Mus musculus GSE109131 ... MA0113.3
NR3C1 BMDM (bone marrow-derived macrophages) Treatment: 100 nM LPS for 45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6 Permissive Mus musculus GSE109131 ... MA0113.3
NR3C1 BMDM (bone marrow-derived macrophages) Treatment: 10 ng/ml LPS + 100 nM Dex for 45 minutes Age: 8-12 weeks Sex: male Strain: C57BL/6 Permissive Robust Mus musculus GSE109131 ... MA0113.3
NR3C1 BMDM (bone marrow-derived macrophages) Treatment: untrated Age: 8-12 weeks Sex: male Strain: C57BL/6 Permissive Mus musculus GSE109131 ... MA0113.3
NR3C1 mammary gland Wap-delE1; Lactation day 1 Permissive Mus musculus GSE115368 ... MA0113.3
NR3C1 mammary gland Wap-delE1-delE2-delE3; Lactation day 1 Permissive Mus musculus GSE115368 ... MA0113.3
NR3C1 kidney WT; lactation day 10 Permissive Robust Mus musculus GSE115368 ... MA0113.3
NR3C1 kidney Wap-E12-Ramp3; lactation day 10 Permissive Robust Mus musculus GSE115368 ... MA0113.3
NR3C1 mammary gland Wap-delE1-delE2-delE3; lactation day 10 Permissive Robust Mus musculus GSE115368 ... MA0113.3
NR3C1 mammary gland Wap-delE1-delE3; Lactation day 10 Permissive Robust Mus musculus GSE115368 ... MA0113.3
NR3C1 mammary gland Wap-delE1-delE3; Lactation day 1 Permissive Mus musculus GSE115368 ... MA0113.3
NR3C1 mammary gland Wap-delE1; Lactation day 10 Permissive Robust Mus musculus GSE115368 ... MA0113.3
NR3C1 mammary gland WT; Lactation day 10 Permissive Robust Mus musculus GSE115368 ... MA0113.3
NR3C1 mammary gland WT; Lactation day 1 Permissive Mus musculus GSE115368 ... MA0113.3
NR3C1 AtT-20 (pituitary tumor) Treatment: 30 minutes LIF and Dexamethasone Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Neo Permissive Robust Mus musculus GSE87180 ... MA0113.3
NR3C1 AtT-20 (pituitary tumor) Treatment: 30 minutes LIF and Dexamethasone Cell type: pituitary corticotroph cell Passage: 10-20 Genotype: expressing 3x flag-Pax7 Permissive Robust Mus musculus GSE87180 ... MA0113.3
NR3C1 SUP-B15 (Childhood B acute lymphoblastic leukemia) Treatment: 90min with 0.02% ethanol Genotype: traslocation t(9;22)(q34;11) ? BCR-ABL1 e1-a2 fusion Permissive Homo sapiens GSE107584 ... MA0113.3
NR3C1 SUP-B15 (Childhood B acute lymphoblastic leukemia) Treatment: 1uM dexamethasone in 0.02% ethanol Genotype: traslocation t(9;22)(q34;11) ? BCR-ABL1 e1-a2 fusion Permissive Robust Homo sapiens GSE107584 ... MA0113.3
NR3C1 liver Strain: C57BL/6 Genotype: wild type Treament: pre-prandial injection with vehicle Permissive Robust Mus musculus GSE119713 ... MA0113.3
NR3C1 liver Strain: C57BL/6 Genotype: wild type Treament: Night restricted feeding, pre-prandial injection with vehicle Permissive Robust Mus musculus GSE119713 ... MA0113.3
NR3C1 liver Strain: C57BL/6 Genotype: wild type Treament: Night restricted feeding, pre-prandial injection with 1mg/kg dex Permissive Robust Mus musculus GSE119713 ... MA0113.3
NR3C1 liver Strain: C57BL/6 Genotype: wild type Treament: none Permissive Robust Mus musculus GSE119713 ... MA0113.3
NR3C1 liver Strain: C57BL/6 Genotype: wild type Treament: Night restricted feeding Permissive Robust Mus musculus GSE119713 ... MA0113.3
NR3C1 monocytes of peripheral blood Treatment: treated with DMSO (Veh control) for 4 hours; Source: Adult Human Peripheral Blood; Donor:Buffycoat 12; Permissive Homo sapiens GSE109438 ... MA0113.3
NR3C1 monocytes of peripheral blood Treatment: treated with 1 micromolar (1uM) TA for 4 hours; Source: Adult Human Peripheral Blood; Donor:Buffycoat 12; Permissive Robust Homo sapiens GSE109438 ... MA0113.3
NR3C1 macrophages Treatment: treated with DMSO (Veh control) for 4 hours; Source: Adult Human Peripheral Blood; Donor:Buffycoat 11; Permissive Homo sapiens GSE109438 ... MA0113.3
NR3C1 macrophages Treatment: treated with 1 micromolar (1uM) TA for 4 hours; Source: Adult Human Peripheral Blood; Donor:Buffycoat 11; Permissive Robust Homo sapiens GSE109438 ... MA0113.3
NR3C1 MEF (mouse embryonic fibroblasts) Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR; Permissive Robust Mus musculus GSE108634 ... MA0113.3
NR3C1 3617-KOGR (mouse adenocarcinoma) Treatment: no treatment; Genotype: knockout of endogenous GR; Permissive Mus musculus GSE108634 ... MA0113.3
NR3C1 3617-KOGR (mouse adenocarcinoma) Treatment: no treatment; Genotype: knockout of endogenous GR; Permissive Mus musculus GSE108634 ... MA0113.3
NR3C1 3617-KOGR (mouse adenocarcinoma) Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing GFP-GR; Permissive Mus musculus GSE108634 ... MA0113.3
NR3C1 3617-KOGR (mouse adenocarcinoma) Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing GFP-GR; Permissive Robust Mus musculus GSE108634 ... MA0113.3
NR3C1 3617-KOGR (mouse adenocarcinoma) Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing GFP-GR; Permissive Mus musculus GSE108634 ... MA0113.3
NR3C1 3617-KOGR (mouse adenocarcinoma) Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing GFP-GR; Permissive Robust Mus musculus GSE108634 ... MA0113.3
NR3C1 3617-KOGR (mouse adenocarcinoma) Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra; Permissive Mus musculus GSE108634 ... MA0113.3
NR3C1 3617-KOGR (mouse adenocarcinoma) Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra; Permissive Robust Mus musculus GSE108634 ... MA0113.3
NR3C1 MEF (mouse embryonic fibroblasts) Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR; Permissive Mus musculus GSE108634 ... MA0113.3
NR3C1 MEF (mouse embryonic fibroblasts) Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing GFP-GR; Permissive Mus musculus GSE108634 ... MA0113.3
NR3C1 MEF (mouse embryonic fibroblasts) Treatment: no treatment; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra; Permissive Mus musculus GSE108634 ... MA0113.3
NR3C1 MEF (mouse embryonic fibroblasts) Treatment: Dexamethasone 100 nM for 1 hr; Genotype: knockout of endogenous GR, stably expressing P481R GFP-GRtetra; Permissive Robust Mus musculus GSE108634 ... MA0113.3
NR3C1 BWTG3(Hepatocellular carcinoma of the mouse) Treatment: none; Permissive Mus musculus GSE123953 ... MA0113.3
NR3C1 BWTG3(Hepatocellular carcinoma of the mouse) Treatment: 1uM Dex (Sigma, D-2915) for 3 hrs; Permissive Robust Mus musculus GSE123953 ... MA0113.3
NR3C1 BWTG3(Hepatocellular carcinoma of the mouse) Treatment: 1uM Dex (Sigma, D-2915) and 1000u/ml recombinant TNF for 3 hrs; Permissive Mus musculus GSE123953 ... MA0113.3
NR3C1 BWTG3(Hepatocellular carcinoma of the mouse) Treatment: 1000u/ml recombinant TNF for 3 hrs; Permissive Mus musculus GSE123953 ... MA0113.3
NR3C1 IMR90 (lung fibroblasts) GLUCC Permissive Robust Homo sapiens ERP007081 MA0113.3
NR3C1 K562 (myelogenous leukemia) GLUCC Permissive Homo sapiens ERP007081 MA0113.3
NR3C1 U2OS (osteosarcoma) GLUCC Permissive Robust Homo sapiens ERP007081 MA0113.3
NR3C1 DMI Permissive Robust Homo sapiens GSE68864 MA0113.3
NR3C1 RS4-11 (adult B acute lymphoblastic leukemia) DEX Permissive Robust Homo sapiens GSE71616 MA0113.3
NR3C1 A549 (lung carcinoma) Permissive Homo sapiens ENCSR116TFA MA0113.3
NR3C1 GM12878 (female B-cells lymphoblastoid cell line) Permissive Homo sapiens ENCSR904YPP MA0113.3
NR3C1 K562 (myelogenous leukemia) Permissive Homo sapiens ENCSR325DER MA0113.3
NR3C1 A549 (lung carcinoma) Permissive Robust Homo sapiens ENCSR355HLV MA0113.3
NR3C1 K562 (myelogenous leukemia) Permissive Homo sapiens ENCSR494UQJ MA0113.3
NR3C1 3T3-L1-derived preadipocytes Permissive Robust Mus musculus GSE21898 ... MA0113.3
NR3C1 MDA-MB-231 (breast adenocarcinoma) Permissive Homo sapiens GSE56022 ... MA0113.3
NR3C1 acute myeloblastic leukemia Permissive Homo sapiens GSE58266 ... MA0113.3
NR3C1 3134 (mammary adenocarcinoma) Permissive Mus musculus GSE61234 ... MA0113.3
NR3C1 monocyte-derived macrophages Permissive Robust Homo sapiens GSE61878 ... MA0113.3
NR3C1 burst-forming unit erythroid Permissive Mus musculus GSE62788 ... MA0113.3
NR3C1 white adipose tissue Permissive Robust Mus musculus GSE64458 ... MA0113.3
NR3C1 epididymal white adipose tissue Permissive Robust Mus musculus GSE64458 ... MA0113.3
NR3C1 embryonic fibroblasts Permissive Mus musculus GSE69947 ... MA0113.3
NR3C1 brown preadipocytes Permissive Mus musculus GSE76619 ... MA0113.3
NR3C1 brown preadipocytes Permissive Robust Mus musculus GSE76619 ... MA0113.3
NR3C1 brown preadipocytes Permissive Robust Mus musculus GSE76619 ... MA0113.3
NR3C1 HepG2 (hepatoblastoma) Permissive Robust Homo sapiens GSE85343 ... MA0113.3
NR3C1 MM1.S (plasma cell myeloma) Permissive Homo sapiens GSE63209 MA0113.3
NR3C1 DMSO Permissive Homo sapiens GSE24518 MA0113.3
NR3C1 GRKD_DMSO Permissive Homo sapiens GSE24518 MA0113.3
NR3C1 GRKD_TA_TNFA Permissive Homo sapiens GSE24518 MA0113.3
NR3C1 P65KD_DMSO Permissive Homo sapiens GSE24518 MA0113.3
NR3C1 P65KD_TA_TNFA Permissive Robust Homo sapiens GSE24518 MA0113.3
NR3C1 TA Permissive Robust Homo sapiens GSE24518 MA0113.3
NR3C1 TA_TNFA Permissive Robust Homo sapiens GSE24518 MA0113.3
NR3C1 TNFA Permissive Homo sapiens GSE24518 MA0113.3
NR3C1 LNCaP (prostate carcinoma) 1F5 Permissive Robust Homo sapiens GSE30623 MA0113.3
NR3C1 LNCaP (prostate carcinoma) 1F5_SIFOXA1 Permissive Robust Homo sapiens GSE30623 MA0113.3
NR3C1 LCL (lymphoblastoid cell line) DEX Permissive Homo sapiens GSE45638 MA0113.3
NR3C1 LCL (lymphoblastoid cell line) ETOH Permissive Homo sapiens GSE45638 MA0113.3
NR3C1 U2OS (osteosarcoma) SHHIC5 Permissive Robust Homo sapiens GSE65847 MA0113.3
NR3C1 U2OS (osteosarcoma) SHNS Permissive Robust Homo sapiens GSE65847 MA0113.3
NR3C1 NALM-6 (adult B acute lymphoblastic leukemia) CASP1 Permissive Robust Homo sapiens GSE67046 MA0113.3
NR3C1 MCF7 (Invasive ductal breast carcinoma) DEX Permissive Robust Homo sapiens GSE72249 MA0113.3
NR3C1 T47D (invasive ductal carcinoma) DEX Permissive Robust Homo sapiens GSE72249 MA0113.3
NR3C1 ZR-75-1 (invasive ductal carcinoma) DEX Permissive Robust Homo sapiens GSE72249 MA0113.3
NR3C1 NALM-6 (adult B acute lymphoblastic leukemia) Permissive Robust Homo sapiens GSE67046 MA0113.3
NR3C1 MCF7 (Invasive ductal breast carcinoma) Permissive Homo sapiens GSE72249 MA0113.3
NR3C1 T47D (invasive ductal carcinoma) Permissive Homo sapiens GSE72249 MA0113.3
NR3C1 ZR-75-1 (invasive ductal carcinoma) Permissive Homo sapiens GSE72249 MA0113.3
NR3C1 IMR90 (lung fibroblasts) Permissive Robust Homo sapiens ERP007093 MA0113.3
NR3C1 IMR90 (lung fibroblasts) Permissive Homo sapiens ERP007093 MA0113.3